CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Open-market buy Director bought 6,758 shares at $2.92 ($19,733)
- 4 Open-market buy CEO bought 12,302 shares at $2.85 ($34,999)
- 8-K Event Executive or director change
- 4 Open-market buy CFO bought 20,000 shares at an average $2.89 ($57,700)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 10,000 shares at $4.70 ($47,000)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- 4 Grant or award CFO acquired 77,000 shares (grant or award)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- 4 Open-market buy Director bought 1,250,000 shares at $4.00 ($5,000,000)
- 4 Grant or award Chief Medical Officer acquired 77,000 shares (grant or award)
- 4 Grant or award CEO acquired 204,000 shares (grant or award)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 6 of 38 · 760 filings